US digital medical investment shrinks, China's investment quota continues to increase
According to the research released by Macomb Capital Group, the volume of investment in the medical information technology industry in the third quarter was much higher than that in the second quarter. However, in terms of funds raised by the listing, the third quarter was slightly lower than the second quarter. However, these figures are still exciting, as the number of transactions in the third quarter so far is much higher than in the second quarter. The medical information technology industry raised a total of $956 million in 212 transactions worldwide, compared with 161 transactions in the previous quarter, reaching $1.8 billion. Digital medical companies have attracted $3.6 billion in venture capital since 2010. Macomb executives pointed out that another interesting feature of the third quarter was that overseas companies raised a record high. “The proportion of companies in other countries outside the United States has reached a record high,†Raj Prabhu, co-founder and CEO of Macomb Capital Group, pointed out at the press conference. “The consumer-oriented company attracted most of the quarter. Funding, and mergers and acquisitions involving companies with applications are another matter." Customer-centric technology, such as mobile medical and telemedicine , easily won most of the money – accounting for 65% of the wind's investment in the quarter, with 140 transactions totaling $623 million. Telemedicine recorded a record high volume in the quarter, with 16 transactions and a transaction volume of $101 million. Revenue and expenditure management and data analysis also performed well, reaching $75 million and $71 million, respectively. In the third quarter, China's DXY became one of the five biggest winners in the third quarter. The company positioned itself as a healthcare community group with a credit of $70 million; Proteus Digital Healthcare's venture capital reached $52 million; and Teladoc reached $50.3 million. US dollar; Dr. Chun Yu, a Chinese medical consulting application company, raised $50 million, and payer software company HealthEdge credited $30 million. Domestic and foreign investment and financing case highlights In contrast, the amount of investment in the domestic digital medical field is also increasing, among which the mobile medical market is the most popular. The state of chicken blood in the field of medical technology is constantly heating up, and more and more creative thinking, creative people with lofty ideals and capital hot money are constantly gathering in this field. As a major focus in this diversified environment, mobile healthcare not only brings us a convenient experience like never before, but at the same time, its products and services are constantly adapting to the market, but also affecting more and more consumers. Living habits and health concepts, and this will inevitably give birth to more huge market opportunities. We are the only hemp manufacturer that integrates planting, processing, sales and transportation, so that we can guarantee 100% traceability of every customer's order. As the world's leading producer and supplier of hemp food ingredients, we have obtained many international food certificates, including HACCP, Organic Certificate, BRC, Kosher, Halal, etc. Quality and food safety have been favored by European and American customers. So far, we have achieved comprehensive cooperation with distributors in Europe and America, and the export volume has ranked first. Industrial hemp,organic hemp protein,organic hemp oil,organic hemp hearts Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayinc.com